Novartis Investigative Site

Faridabad, Haryana 121002

0 studies enrolling now · 3 studies all time

What they study most

IgA Nephropathy, Immunoglobulin A Nephropathy, Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndromes, Triple Negative Breast Neoplasms

Studies at this site

• Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss — Stopped early
• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) — Stopped early